Search
Xilio Therapeutics Inc
XLOAdd to Watchlist
9.110USD
+0.030+0.33%
Close 07-31 16:00（ET）Quotes delayed by 15 min
52.68MMarket Cap
LossP/E TTM
Institutional Confidence
Currency: USD Updated: 2026-07-31The current institutional shareholding score of Xilio Therapeutics Inc is 5.00, ranking 132 out of 385 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 28.99%, representing a quarter-over-quarter decrease of 18.25%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.86% of shares outstanding, with 3.80% increase in holdings.
Institutional Shareholding
Shareholder Activity
Name
Shares Held
Chg %
Gilead Sciences, Inc
GKCC, LLC
Frazier Life Sciences Management, L.P.
AbbVie, Inc.
Coastlands Capital LP
Sio Capital Management, LLC
StemPoint Capital LP
Merck & Co Inc
1
2